Allergan, Inc
Article Abstract:
The shares of Allergan Inc. have a below average price appreciation potential over the 2010-2012 timeframe. The Irvine, California-based firm is a drug and medical device company. Drugs that treat eye, neuromuscular, and skin disorders, are manufactured by the company.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Allergan Inc., AGN
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Celgene Corp
Article Abstract:
The price appreciation potential of the shares of Celgene Corp. for the years 2010-2012 is discussed. The Summit, New Jersey-based company is engaged in the development of orally administered drugs for cancer and inflammatory diseases.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Celgene Corp., CELG
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Pharmaceutical industry, Stocks, Securities, Stock prices, Company securities, Analyst report
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.